Aveo Pharmaceuticals Inc (NASDAQ:AVEO)

Data as of 3:59pm ET
 0.00 / 0.00%
Today’s Change
Today|||52-Week Range
Health Technology

Company Description

AVEO Pharmaceuticals, Inc. is a cancer therapeutics company, which is discovering, developing and commercializing targeted therapies to treat patients with cancer. Its proprietary human response platform provides the company unique insights into cancer and related disease biology and is being leveraged in the discovery and clinical development of its therapeutic candidates. The company's product candidates include AV-203, ficlatuzumab, tivozanib and AV-380. AVEO Pharmaceuticals was founded by Ronald A. DePinho, Lynda Chin and Kenneth E. Weg on October 19, 2001 and is headquartered in Cambridge, MA.

Contact Information

AVEO Pharmaceuticals, Inc.
650 East Kendall Street
Cambridge Massachusetts 02142
P:(617) 299-5000
Investor Relations:
(617) 299-5810



Mutual fund holders6.47%
Other institutional35.52%
Individual stakeholders13.23%

Top Executives

Tuan Ha-NgocPresident, Chief Executive Officer, CFO & Director
Jeno GyurisChief Scientific Officer & Senior Vice President
Joseph VittiglioSecretary, General Counsel & Senior Vice President
Michael P. BaileyChief Business Officer
Matthew D. DallasTreasurer, Chief Accounting Officer & VP-Finance

To view my watchlist

Not a member yet?

Sign up now for a free account
Market indexes are shown in real time, except for the DJIA, which is delayed by two minutes. All times are ET. Disclaimer Morningstar: © 2014 Morningstar, Inc. All Rights Reserved. Disclaimer The Dow Jones IndexesSM are proprietary to and distributed by Dow Jones & Company, Inc. and have been licensed for use. All content of the Dow Jones IndexesSM © 2014 is proprietary to Dow Jones & Company, Inc. Chicago Mercantile Association. The market data is the property of Chicago Mercantile Exchange Inc. and its licensors. All rights reserved. FactSet Research Systems Inc. 2014. All rights reserved. Most stock quote data provided by BATS.